| Date Filed | Type | Description |
| 03/05/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2014 |
4
| Christmas Patrick J. (General Counsel) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| Nielson Steven (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| McInnis Joe (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| Vergis Janet S. (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| MCHUGH THOMAS S (CFO) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| Goldfarb James M. (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| Norden Gregory (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 03/05/2014 |
4
| DIVIS GREG J (CEO and President) has filed a Form 4 on K-V Pharmaceutical Co |
| 11/20/2013 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Bought 25,000 shares
@ $46.5, valued at
$1.2M
|
|
| 11/15/2013 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Bought 57,162 shares
@ $42.75, valued at
$2.4M
Bought 50,000 shares
@ $44.5, valued at
$2.2M
|
|
| 11/01/2013 |
4
| Vergis Janet S. (Director) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Granted 15,000 options to buy
@ $28.8, valued at
$432k
Granted 5,000 options to buy
@ $32, valued at
$160k
Granted 3,751 restricted stock units
@ $0 |
|
| 11/01/2013 |
3
| Vergis Janet S. (Director) has filed a Form 3 on K-V Pharmaceutical Co |
| 10/25/2013 |
4
| MAHADY JOSEPH M (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 10/23/2013 |
4
| Goldfarb James M. (Director) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Granted 15,000 options to buy
@ $28.8, valued at
$432k
Granted 5,000 options to buy
@ $32, valued at
$160k
Granted 3,751 restricted stock units
@ $0 |
|
| 10/23/2013 |
3
| Goldfarb James M. (Director) has filed a Form 3 on K-V Pharmaceutical Co |
| 10/23/2013 |
4
| Norden Gregory (Director) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Granted 15,000 options to buy
@ $28.8, valued at
$432k
Granted 5,000 options to buy
@ $32, valued at
$160k
Granted 3,751 restricted stock units
@ $0 |
|
| 10/23/2013 |
3
| Norden Gregory (Director) has filed a Form 3 on K-V Pharmaceutical Co |
| 10/15/2013 |
3
| Haron Eric (Director) has filed a Form 3 on K-V Pharmaceutical Co |
| 10/15/2013 |
3
| McInnis Joe (Director) has filed a Form 3 on K-V Pharmaceutical Co |
| 10/11/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/04/2013 |
4
| Christmas Patrick J. (General Counsel) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Granted 86,806 restricted stock units
@ $0
Granted 40,327 options to buy
@ $20, valued at
$806.5k
|
|
| 10/04/2013 |
3
| Siegel Jonathan B. (Director) has filed a Form 3 on K-V Pharmaceutical Co |
| 10/04/2013 |
4
| MCHUGH THOMAS S (CFO) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Granted 86,806 restricted stock units
@ $0
Granted 40,327 options to buy
@ $20, valued at
$806.5k
|
|
| 10/04/2013 |
4
| DIVIS GREG J (CEO and President) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Granted 173,611 restricted stock units
@ $0
Granted 80,653 options to buy
@ $20, valued at
$1.6M
|
|
| 09/27/2013 |
4
| Stancic Ana (Director) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Disposed of 10,000 options to buy
@ $1.62, valued at
$16.2k
Disposed of 7,500 options to buy
@ $1.14, valued at
$8.6k
Disposed of 20,000 options to buy
@ $1.49, valued at
$29.8k
Disposed of 20,000 options to buy
@ $0.94, valued at
$18.8k
|
|
| 09/27/2013 |
4
| BALDINI ROBERT E (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 09/27/2013 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Sold 199,000 shares
@ $40, valued at
$8M
|
|
| 09/26/2013 |
4
| Dow Mark A. (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 09/26/2013 |
4
| BENTLEY GREGORY SMITH (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 09/26/2013 |
4
| Hermelin David S (Director) has filed a Form 4 on K-V Pharmaceutical Co |
| 09/25/2013 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co|
Txns:
| Bought 150,000 shares
@ $40, valued at
$6M
|
|
| 09/24/2013 |
4
| Christmas Patrick J. (General Counsel) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/|
Txns:
| Disposed of 40,000 options to buy
@ $3.32, valued at
$132.8k
Disposed of 40,000 options to buy
@ $1.32, valued at
$52.8k
|
|
| 09/20/2013 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/|
Txns:
| Disposed of 1,000 shares
@ $0
Disposed of 10,000 options to buy
@ $1.62, valued at
$16.2k
Disposed of 7,500 options to buy
@ $1.02, valued at
$7.7k
Disposed of 20,000 options to buy
@ $1.49, valued at
$29.8k
Disposed of 20,000 options to buy
@ $0.94, valued at
$18.8k
|
|
|